Chelsea Counsel CO Johnson & Johnson Transaction History

Chelsea Counsel CO

$200 Million
Q3 2024

A detailed history of Chelsea Counsel CO transactions in Johnson & Johnson stock. As of the latest transaction made, Chelsea Counsel CO holds 23,624 shares of JNJ stock, worth $3.45 Million. This represents 1.91% of its overall portfolio holdings.

Number of Shares

23,624

Previous 24,685 4.3%

Holding current value

$3.45 Million

Previous $3.61 Million 6.13%

% of portfolio

1.91%

Previous 1.82%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 21, 2024	SELL	$145.48 - $167.38 $154,354 - $177,590	-1,061 Reduced 4.3%	23,624 $3.83 Million
Q2 2024 Nov 21, 2024	SELL	$144.38 - $157.78 $37,971 - $41,496	-263 Reduced 1.05%	24,685 $3.61 Million
Q1 2024 Jun 14, 2024	SELL	$155.22 - $162.74 $280,327 - $293,908	-1,806 Reduced 6.75%	24,948 $3.95 Million
Q4 2023 Feb 21, 2024	SELL	$145.6 - $158.88 $235,435 - $256,908	-1,617 Reduced 5.7%	26,754 $4.19 Million
Q3 2023 Nov 22, 2023	SELL	$155.75 - $174.48 $1.6 Million - $1.8 Million	-10,295 Reduced 26.63%	28,371 $4.42 Million
Q2 2023 Nov 22, 2023	SELL	$154.35 - $166.11 $38,896 - $41,859	-252 Reduced 0.65%	38,666 $6.4 Million
Q1 2023 May 19, 2023	SELL	$151.05 - $180.26 $75,525 - $90,130	-500 Reduced 1.27%	38,918 $6.03 Million
Q4 2022 Feb 23, 2023	SELL	$160.2 - $179.79 $296,370 - $332,611	-1,850 Reduced 4.48%	39,418 $6.96 Million
Q3 2022 Oct 31, 2022	SELL	$161.33 - $179.52 $586,434 - $652,555	-3,635 Reduced 8.1%	41,268 $6.74 Million
Q2 2022 Aug 01, 2022	SELL	$168.19 - $186.01 $84,935 - $93,935	-505 Reduced 1.11%	44,903 $7.97 Million
Q1 2022 May 24, 2022	SELL	$158.14 - $179.59 $54,242 - $61,599	-343 Reduced 0.75%	45,408 $8.05 Million
Q4 2021 May 23, 2022	SELL	$155.93 - $173.01 $39,762 - $44,117	-255 Reduced 0.55%	45,751 $7.83 Million
Q3 2021 Feb 10, 2022	BUY	$161.5 - $179.47 $119,510 - $132,807	740 Added 1.63%	46,006 $7.43 Million
Q2 2021 Feb 10, 2022	BUY	$159.48 - $171.07 $399,497 - $428,530	2,505 Added 5.86%	45,266 $7.46 Million
Q1 2021 Feb 10, 2022	SELL	$153.07 - $170.48 $28,930 - $32,220	-189 Reduced 0.44%	42,761 $7.03 Million
Q4 2020 Mar 08, 2022	SELL	$137.11 - $157.38 $173,855 - $199,557	-1,268 Reduced 2.87%	42,950 $6.76 Million
Q3 2020 May 06, 2022	SELL	$140.38 - $153.83 $251,982 - $276,124	-1,795 Reduced 3.9%	44,218 $6.58 Million
Q2 2020 May 06, 2022	BUY	$128.81 - $155.51 $144,267 - $174,171	1,120 Added 2.49%	46,013 $6.47 Million
Q1 2020 Jun 12, 2020	SELL	$111.14 - $153.99 $50,124 - $69,449	-451 Reduced 0.99%	44,893 $5.89 Million
Q4 2019 Mar 23, 2020	SELL	$127.5 - $146.44 $249,900 - $287,022	-1,960 Reduced 4.14%	45,344 $6.61 Million
Q3 2019 Mar 27, 2020	BUY	$126.95 - $142.14 $463,748 - $519,237	3,653 Added 8.37%	47,304 $6.12 Million
Q3 2019 Mar 23, 2020	SELL	$126.95 - $142.14 $1.35 Million - $1.51 Million	-10,655 Reduced 19.62%	43,651 $0
Q2 2019 Dec 09, 2019	SELL	$131.15 - $144.24 $12,852 - $14,135	-98 Reduced 0.18%	54,306 $7.56 Million
Q1 2019 Dec 09, 2019	SELL	$125.72 - $139.79 $239,370 - $266,160	-1,904 Reduced 3.38%	54,404 $7.61 Million
Q4 2018 Dec 09, 2019	BUY	$122.84 - $147.84 $6,264 - $7,539	51 Added 0.09%	56,308 $7.27 Million
Q3 2018 Dec 09, 2019	BUY	$121.58 - $142.88 $506,867 - $595,666	4,169 Added 8.0%	56,257 $7.77 Million
Q2 2018 Oct 03, 2018	SELL	$119.4 - $131.76 $999,855 - $1.1 Million	-8,374 Reduced 13.85%	52,088 $6.32 Million
Q1 2018 Oct 03, 2018	SELL	$125.1 - $148.14 $1.05 Million - $1.24 Million	-8,391 Reduced 12.19%	60,462 $7.75 Million
Q4 2017 Jan 12, 2018	SELL	$131.22 - $143.62 $1.25 Million - $1.37 Million	-9,535 Reduced 12.16%	68,853 $9.62 Million
Q3 2017 Jan 12, 2018	SELL	$129.47 - $135.38 $122,608 - $128,204	-947 Reduced 1.19%	78,388 $10.2 Million
Q2 2017 Jan 22, 2018	BUY	N/A	79,335	79,335 $10.5 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chelsea Counsel CO, based on Form 13F filings with the SEC.

News

Stay updated on Chelsea Counsel CO with notifications on news.

Account

Chelsea Counsel CO Johnson & Johnson Transaction History